Tenderwize
Wróć do wyszukiwania

Open house discount agreements for the active ingredient Baricitinib, ATC L04AF02

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 187 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Baricitinib, ATC L04AF02

40/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

40 / 100

Złożoność

20 / 100

Czynniki ryzyka

The buyer reserves the right to replace open-house contracts with exclusive discount agreements at any time, automatica...

No commitment on minimum quantities or volumes; actual uptake depends on prescribing behavior and patient needs.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Supply of pharmaceutical products containing Baricitinib
  • Non-exclusive discount agreements under §130a Abs. 8/130c Abs. 1 SGB V
Pokaż pełne podsumowanie

This is an open-house model for non-exclusive discount agreements (Rabattverträge) on the active ingredient Baricitinib (ATC L04AF02) by AOK Rheinland-Pfalz/Saarland. The procedure is not a formal EU procurement but a voluntary transparency publication. All interested pharmaceutical companies can join at any time during the 24-month maximum contract duration, with first possible start on 01.05.2025. No estimated value is provided. The contract may be replaced by exclusive agreements during its term.

Ryzyka

The buyer reserves the right to replace open-house contracts with exclusive discount agreements at any time, automatica...

No commitment on minimum quantities or volumes; actual uptake depends on prescribing behavior and patient needs.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Pharmaceutical companies only
  • Products must be authorized and marketable in Germany
  • Proof of marketability via Lauer-Taxe listing or AMIce database

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria specified; all participants are accepted under uniform conditions.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open house discount agreements for the active ingredient Baricitinib, ATC L04AF02

Non-exclusive discount agreements for Baricitinib. All pharmaceutical companies can participate under uniform conditions. Contracts run for up to 24 months, starting 01.05.2025. The buyer may replace these with exclusive contracts at any time. First deadline for initial agreements: 31.03.2025; thereafter, monthly deadlines apply.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

Apr 2025 - Apr 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria specified; all participants are accepted under uniform conditions.

Termin

Expired Mar 31, 2025

Szczegóły zamówienia

Data publikacji
12 Mar 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
164264-2025

Dokumenty (1)

Podobne przetargi